$CERO SEC Filings

Filed On	Filing
07 Oct 2026	8-K: Entry into a Material Definitive Agreement This STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of October 6, 2026, is made by and among CERo Therapeutics Holdings, Inc., a Delaware corporation (“Seller”), and SRX Global Inc., a Delaware corporation formerly known as SRX He...
31 Aug 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
14 Aug 2026	PROSPECTUS SUPPLEMENT
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	QUARTERLY REPORT
17 Jul 2026	PROSPECTUS SUPPLEMENT
17 Jul 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
13 Jul 2026	25-NSE
26 Jun 2026	PROSPECTUS SUPPLEMENT
26 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
29 May 2026	PROSPECTUS SUPPLEMENT
29 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
15 May 2026	PROSPECTUS SUPPLEMENT
15 May 2026	QUARTERLY REPORT
01 May 2026	PROSPECTUS SUPPLEMENT
01 May 2026	PROSPECTUS SUPPLEMENT
01 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
30 Apr 2026	AMENDMENT NO. 1 TO FORM 10-K
21 Apr 2026	Form 3: Francois Eric, Director No securities owned
21 Apr 2026	Form 4: Francois Eric, Director Granted 1,823,278 Stock Option (Right to Buy)

Comments